SG11201609954VA - Highly drug-loaded poly(alkyl 2-cyanoacrylate) nanocapsules - Google Patents

Highly drug-loaded poly(alkyl 2-cyanoacrylate) nanocapsules

Info

Publication number
SG11201609954VA
SG11201609954VA SG11201609954VA SG11201609954VA SG11201609954VA SG 11201609954V A SG11201609954V A SG 11201609954VA SG 11201609954V A SG11201609954V A SG 11201609954VA SG 11201609954V A SG11201609954V A SG 11201609954VA SG 11201609954V A SG11201609954V A SG 11201609954VA
Authority
SG
Singapore
Prior art keywords
nanocapsules
cyanoacrylate
alkyl
loaded poly
highly drug
Prior art date
Application number
SG11201609954VA
Inventor
Anamarija Curic
Jan-Peter Möschwitzer
Regina Reul
Original Assignee
Abbvie Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Deutschland filed Critical Abbvie Deutschland
Publication of SG11201609954VA publication Critical patent/SG11201609954VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
SG11201609954VA 2014-05-30 2015-05-29 Highly drug-loaded poly(alkyl 2-cyanoacrylate) nanocapsules SG11201609954VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462005182P 2014-05-30 2014-05-30
EP14170536 2014-05-30
PCT/EP2015/061933 WO2015181346A1 (en) 2014-05-30 2015-05-29 Highly drug-loaded poly(alkyl 2-cyanoacrylate) nanocapsules

Publications (1)

Publication Number Publication Date
SG11201609954VA true SG11201609954VA (en) 2016-12-29

Family

ID=50842134

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201609954VA SG11201609954VA (en) 2014-05-30 2015-05-29 Highly drug-loaded poly(alkyl 2-cyanoacrylate) nanocapsules

Country Status (9)

Country Link
US (1) US20170189344A1 (en)
EP (1) EP3148590A1 (en)
JP (1) JP6612333B2 (en)
CN (1) CN106794150B (en)
AU (1) AU2015265874B2 (en)
CA (1) CA2946807A1 (en)
IL (1) IL248695B (en)
SG (1) SG11201609954VA (en)
WO (1) WO2015181346A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7454386B2 (en) * 2020-01-27 2024-03-22 三菱鉛筆株式会社 Water-based ink composition for writing instruments

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300875D0 (en) * 1993-01-18 1993-03-10 Ucb Sa Nanocapsule containing pharmaceutical compositions
FR2805761B1 (en) * 2000-03-02 2002-08-30 Mainelab LIPID NANOCAPSULES, METHOD OF PREPARATION AND USE AS A MEDICAMENT
CA2555921A1 (en) * 2004-02-13 2005-09-15 Nod Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of making and using same
FR2910286B1 (en) * 2006-12-20 2009-04-17 Oreal COMPOSITION COMPRISING ENCAPSULATED SILICONE COMPOUNDS
CN101084882B (en) * 2007-06-21 2011-03-23 复旦大学 Polyalkylcyanoacrylate nano-capsule and preparation method and application thereof
EP2039352A1 (en) * 2007-09-18 2009-03-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
DE102007059752A1 (en) * 2007-12-10 2009-06-18 Bayer Schering Pharma Aktiengesellschaft Functionalized solid polymer nanoparticles containing epothilones
US20110064819A1 (en) * 2008-05-06 2011-03-17 Andrew Beaton Encapsulation of biologically active agents
TW201012489A (en) * 2008-05-06 2010-04-01 Glaxo Group Ltd Encapsulation of biologically active agents

Also Published As

Publication number Publication date
AU2015265874A1 (en) 2016-11-10
US20170189344A1 (en) 2017-07-06
CA2946807A1 (en) 2015-12-03
EP3148590A1 (en) 2017-04-05
WO2015181346A1 (en) 2015-12-03
AU2015265874B2 (en) 2020-05-14
CN106794150B (en) 2021-12-28
CN106794150A (en) 2017-05-31
JP6612333B2 (en) 2019-11-27
JP2017516857A (en) 2017-06-22
IL248695B (en) 2021-09-30
IL248695A0 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
HK1225937A1 (en) Occlusion clip
EP3209527A4 (en) Self-conforming airbag
AP00774S1 (en) Earphone
SG10201506403WA (en) Earset
SG10201502448TA (en) Self-assembling polymers - i
GB201406608D0 (en) Virus
GB201404720D0 (en) Accelerometers
GB201402936D0 (en) Accelerometers
GB201409382D0 (en) Wellbore activation system
EP3169656A4 (en) Regeneration loop clean-up
SG10201503758PA (en) Self-assembling polymers - vi
SG10201506402QA (en) Earset
GB201411484D0 (en) Accelerometers
SG10201503803PA (en) Self-assembling polymers - iv
GB201502252D0 (en) Carrier
GB201410038D0 (en) Accelerometers
SG10201503006PA (en) Self-assembling polymers - ii
ZA201701734B (en) Conjugate for treating malaria
GB201419572D0 (en) Virus
PT3144626T (en) Pyrotechnic carrier structure
SG11201700652PA (en) Modified antimir-138 oligonucleotides
SG10201503799TA (en) Self-assembling polymers - v
SG10201503013RA (en) Self-assembling polymers - iii
GB2589802B (en) Earphone system
GB2522783B (en) Telephony system